Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,362 | 93,035 | 110,930 | 75,154 | 61,897 |
| Marketable Securities | 186,314 | 229,761 | 143,600 | 244,383 | 260,345 |
| Receivables | 87,302 | 80,134 | 82,984 | 38,718 | 34,381 |
| Inventories | 6,356 | 5,875 | 5,548 | 4,090 | 3,932 |
| TOTAL | $392,681 | $437,565 | $371,110 | $379,567 | $374,171 |
| Non-Current Assets | |||||
| PPE Net | 3,627 | 4,022 | 4,320 | 4,561 | 4,853 |
| Intangibles | 110,038 | 113,868 | 109,435 | 105,607 | 103,816 |
| Other Non-Current Assets | 48,842 | 49,736 | 53,716 | 65,574 | 65,959 |
| TOTAL | $162,507 | $167,626 | $167,471 | $175,742 | $174,628 |
| Total Assets | $555,188 | $605,191 | $538,581 | $555,309 | $548,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,912 | 24,800 | 18,225 | 19,134 | 15,374 |
| Accrued Expenses | 104,408 | 126,035 | 105,762 | 81,682 | 77,108 |
| Other current liabilities | 2,100 | 3,194 | 5,353 | 14,291 | 15,757 |
| TOTAL | $125,437 | $159,904 | $135,074 | $189,540 | $182,457 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 331,023 | 330,459 | 329,943 | 333,022 | 333,519 |
| TOTAL | $331,023 | $330,459 | $329,943 | $333,022 | $333,519 |
| Total Liabilities | $456,460 | $490,363 | $465,017 | $522,562 | $515,976 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,993 | 92,242 | 89,472 | 89,139 | 88,805 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -1,509,815 | -1,472,713 | -1,475,442 | -1,501,148 | -1,488,393 |
| Other shareholders' equity | -1,062 | -1,189 | -1,054 | -812 | -843 |
| TOTAL | $98,728 | $114,828 | $73,564 | $32,747 | $32,823 |
| Total Liabilities And Equity | $555,188 | $605,191 | $538,581 | $555,309 | $548,799 |